Trends in age-standardized rate of DALYs per 100,000 with caused by smoking-related strokes in Saudi Arabia during 1990–2021, stratified by gender. by Jaber S. Alqahtani (8822396)

Trends in the age-standardized rate of YLLs per 100,000 caused by smoking-related strokes in Saudi Arabia during 1990–2021, stratified by gender. by Jaber S. Alqahtani (8822396)

Trends in age-standardized rate of deaths per 100,000 caused by smoking-related strokes in Saudi Arabia during 1990–2021, stratified by gender. by Jaber S. Alqahtani (8822396)

Chemical characteristics of rhizosphere soils, roots and leaves of the 29 <i>Synsepalum dulcificum</i> accessions sampled in Benin. by Rabiath F. R. Adigoun (14189090)

Alpha-diversity indices of endophytic bacterial communities associated with <i>Synsepalum dulcificum</i> according to the plant tissue and accessions’ phenotypic group and habitat... by Rabiath F. R. Adigoun (14189090)

Table 1_Imeglimin may affect hemoglobin A1c accuracy via prolongation of erythrocyte lifespan in patients with type 2 diabetes mellitus: insights from the INFINITY clinical trial.d... by Takeshi Osonoi (1951555)

“…While HbA1c and GA decreased and 1,5-AG increased one month after imeglimin initiation, GA and 1,5-AG showed rapid changes compared to the gradual decrease in HbA1c. …”

Purposive Sampling of Traditional Lanna Restaurants. by Vivat Keawdounglek (9710710)

Regional and temporal burden of liver cancer in Kazakhstan (2014–2023). by Ayana Ablayeva (22103708)

Table 1_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.xlsx by Chen Chen (6544)

“…Transcriptomic analysis revealed that AT-1 significantly modulated the expression of S100A8 and S100A9. …”

Image 2_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.tif by Chen Chen (6544)

“…Transcriptomic analysis revealed that AT-1 significantly modulated the expression of S100A8 and S100A9. …”

Image 1_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.tif by Chen Chen (6544)

“…Transcriptomic analysis revealed that AT-1 significantly modulated the expression of S100A8 and S100A9. …”

Illumination distributions (a-c) and variations in illuminance values along the x-axis (d-f) of the CL at different angles. by Fei Li (143236)

Illumination distributions (a-c) and variations in illuminance values along the x-axis (d-f) of the RHL at different angles. by Fei Li (143236)

A funnel plot shows the distribution of HIV-related perceived stigma among people living with HIV/AIDS in Africa. by Gebresilassie Tadesse (18069820)

Neuroprotective effects of Cannabidiol in 5XFAD Mice: Reducing amyloid and tau burden in the dorsal subiculum by Muhammad Kamal Hossain (19814445)

“…Interpretation:</b> Our results showed that CBD treatment led to a significant reduction in Aβ accumulation and a marked decrease in hyperphosphorylated tau in treated mice compared to controls. …”

Raw data. by Camilla Albano (16446679)

“…Conversely, silencing FASN or applying FASN inhibitors (<i>i.e</i>., CMS121 and C75) markedly reduces the infectivity of newly released HSV-1 virions, suggesting that, while initial replication remains unaffected, FASN is crucial for maintaining virion structure and facilitating entry into host cells. Additionally, we show that a source of lipid-rich external factors provided by fetal bovine serum significantly increases HSV-1 infectivity. …”

Data Sheet 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 3_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Table 1_Eculizumab is efficacious and safe in pediatric patients with various forms of hemolytic uremic syndrome: a retrospective clinical experience of a tertiary center.docx by Naama Lax (20998004)

“…We evaluated its efficacy and safety in pediatric patients with TMA sub-types: atypical HUS (aHUS), Shiga toxin-producing Escherichia coli (STEC)-HUS, and transplant-associated TMA (TA-TMA).…”